Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and tolerability of multiple (3)
intradermal doses of RXI-109 at small surgical incisions in the abdominal skin of healthy
volunteers. The effect of RXI-109 versus placebo on scarring at these incision sites will be
evaluated visually, histologically, and by biomarker analysis.